MedTrace Logo

Effects of Lentil Protein Hydrolysate on Blood Pressure Control, Vascular Function and Exercise Performance

NCT06894875 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2025-12-16

No results posted yet for this study

Summary

Examining the safety and tolerability of Lentil Protein Hydrolysate in healthy males and females whilst exploring the effects of a dose range on blood pressure control and vascular function and exercise performance

Conditions

  • Exercise
  • Blood Pressure
  • Vasodilation
  • Vascular Function in Healthy Volunteers
  • Exercise Performance
  • Safety and Tolerability in Healthy Volunteers

Interventions

DIETARY_SUPPLEMENT

Lentil protein hydrolysate

Plant protein hydrolysate

DIETARY_SUPPLEMENT

Placebo MCC micro-crystalline cellulose

Placebo MCC micro-crystalline cellulose

Sponsors & Collaborators

  • Australian Catholic University

    collaborator OTHER

  • Baker Heart and Diabetes Institute

    collaborator OTHER

  • Nuritas Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-24
Primary Completion
2025-12-24
Completion
2026-03-30

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06894875 on ClinicalTrials.gov